![Analysts say high payor coverage, increased CGM adoption bodes well for Abbott, Dexcom - Drug Delivery Business Analysts say high payor coverage, increased CGM adoption bodes well for Abbott, Dexcom - Drug Delivery Business](https://www.drugdeliverybusiness.com/wp-content/uploads/2022/03/Abbott-FreeStyle-Libre-version-1-1.jpg)
Analysts say high payor coverage, increased CGM adoption bodes well for Abbott, Dexcom - Drug Delivery Business
![Kamil @Nerdabetic (he/him/his) on Twitter: "Freestyle Libre 3 announcement video is out! Libre 3 is significantly smaller than L2 and Dexcom G6. Here is a mockup to show the size difference. #freestylelibre3 # Kamil @Nerdabetic (he/him/his) on Twitter: "Freestyle Libre 3 announcement video is out! Libre 3 is significantly smaller than L2 and Dexcom G6. Here is a mockup to show the size difference. #freestylelibre3 #](https://pbs.twimg.com/media/EjQ1VheWoAAC1ZF.jpg)
Kamil @Nerdabetic (he/him/his) on Twitter: "Freestyle Libre 3 announcement video is out! Libre 3 is significantly smaller than L2 and Dexcom G6. Here is a mockup to show the size difference. #freestylelibre3 #
![Dexcom CEO tells investors not to fear new competition from Abbott's Freestyle Libre | MobiHealthNews Dexcom CEO tells investors not to fear new competition from Abbott's Freestyle Libre | MobiHealthNews](https://www.mobihealthnews.com/sites/default/files/Dexcom%20G5_0.png)